Among 648 patients with colorectal cancer, 89 patients with hepatic metastasis (synchronous, 56 ; metachronous, 33) were analyzed regarding their clinicopathological features, therapeutic outcomes and recurrence in the remnant liver after hepatectomy, and the results were as follows :
1)Invasion to the perirectal adipose tissue of the rectum or to the serosal surface of the colon, lymph node metastasis, and lymphatic invasion were all considered to be important risk factors for liver metastasis.
2)The five-year survival rates in patients undergoing resection of either synchronous or metachronous liver metastasis were 36.1 % and 40.1 %, respectively, whereas the prognosis of the patients with liver metastasis who did not undergo surgery was very poor.
3)Recurrent disease was observed in 21 patients after hepatectomy, 14 of which showed recurrent lesions in the residual liver. Re-hepatectomy was performed in 7 patients with remnant liver metastasis, showing good results in the survival period as compared with the non-resected group.
In conclusion, hepatic resection with an adequate surgical margin and postoperative intraarterial chemotherapy for daughter metastasis and occult metastasis was thought to be indispensable for preventing recurrence in the remnant liver. Furthermore, resection of recurrence in the remnant liver should be actively attempted for patients without any recurrent lesions in organs other than the remnant liver.
View full abstract